Ignite Creation Date:
2025-12-24 @ 12:51 PM
Ignite Modification Date:
2026-02-20 @ 4:47 PM
Study NCT ID:
NCT00089661
Status:
COMPLETED
Last Update Posted:
2018-10-17
First Post:
2004-08-09
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast Cancer
Sponsor:
Amgen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-10-01
Start Date Type:
ACTUAL
Primary Completion Date:
2007-05-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-05-27
Completion Date Type:
ACTUAL
First Submit Date:
2004-08-09
First Submit QC Date:
None
Study First Post Date:
2004-08-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-12-22
Results First Submit QC Date:
None
Results First Post Date:
2010-01-26
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2009-11-23
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2018-09-20
Last Update Post Date:
2018-10-17
Last Update Post Date Type:
ACTUAL